-+ 0.00%
-+ 0.00%
-+ 0.00%

Scotiabank Maintains Sector Outperform on Amgen, Raises Price Target to $450

Benzinga·08/05/2026 15:45:41
Listen to the news
Scotiabank analyst Louise Chen maintains Amgen (NASDAQ:AMGN) with a Sector Outperform and raises the price target from $385 to $450.